aod9604 clinical trials safety efficacy and tolerability of in obesity treatment Safety and Efficacy of Approved

AOD9604 targets fat-rich areas and promotes fat breakdown without disturbing the overall metabolic profile

In some protocols, they are used together, with each addressing the part of the problem the other does not reach

3 Extended Administration Pharmacokinetics in DIO Mice Neelakantan et al., Biochemical Pharmacology (2024) This study reported a 28-day once-daily administration protocol of 5-Amino-1MQ in diet-induced obese mice, characterizing plasma pharmacokinetics, tissue distribution, and effects on body composition, fatty liver pathology, and circulating biomarkers

Your health takes priority over any awkwardness